FIELDS OF SPECIALISATION:

Immunotherapy, oncology and covering personalised therapy field (Silvija Jarnjak MD, PhD).

20 years of expertise in clinical trials - such as Lung cancer, Head and Neck cancer, Prostate Cancer and other solid tumour, Skin Cancers,  Haematological Malignancies, Gynaecological Oncology.

Autoimmune Disease's- I would just add in parentesis following - IgA nephropathy, Multiple Sclerosis, Systemic Lupus (SLE).

Female Health (treatment of female sterility, treatment of post-menopausal syndrome).



ABOUT FUTURE CLINICAL TRIALS CONSULTING:

Clinical trials are a crucial part of the drug development process and play a vital role in advancing medical research. These trials are designed to test the safety and efficacy of new treatments, devices, or interventions before they can be approved and made available to the public. During a clinical trial, a carefully selected group of volunteers receives the intervention being tested, while another group receives either a placebo or a standard treatment. The results of these trials are carefully monitored and analyzed to determine the safety and effectiveness of the intervention.

Clinical trials follow strict protocols to ensure the safety of participants and the validity of the results. The trials are conducted in phases, starting with small, early-phase trials to evaluate safety and determine appropriate dosing, followed by larger, later-phase trials to assess efficacy and gather additional safety data. The results of clinical trials inform regulatory agencies about the risks and benefits of new treatments and help guide decisions about whether to approve them for use.

Future Clinical Trials Consulting

Org chart

Teams

Offices